Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens.
Hamed DabiriMahdi Habibi-AnbouhiVahab ZiaeiZahra MoghadasiMajid SadeghizadehEnsiyeh Hajizadeh-SaffarPublished in: Cell journal (2024)
The presented antigens can potentially be used to produce specific pancreatic antibodies that guide CARTreg, bi-specific, or labeling molecules to the pancreas for treatment, detection, or other molecular targeted therapy scopes for type I diabetes.